A randomized controlled cross-over trial evaluating differential responses to antihypertensive drugs (used as mono- or dual-therapy) on the basis of ethnicity: The - comparIsoN oF optimal hypertension RegiMens; part of the ancestry informative markers in HYpertension programme – AIM-HY INFORM trial

Conclusion AIM-HY INFORM is a prospective, open-label, randomized trial which aims to evaluate first and second-line anti-hypertensive therapies for multi-ethnic populations.
Source: American Heart Journal - Category: Cardiology Source Type: research